Results 11 to 20 of about 8,230,812 (271)

Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia

JACC: Advances
Background: Patients with chronic limb threatening ischemia (CLTI) are at risk for major adverse cardiovascular events (MACE), yet few tools exist for risk stratification.
Sreekanth Vemulapalli, MD, Gheorghe Doros, PhD, E. Hope Weissler, MD, W. Schuyler Jones, MD, Shuang Li, MS, Sean M. Obrien, PhD, Joshua A. Beckman, MD, Naomi M. Hamburg, MD, MS, Michael R. Jaff, DO, Michael B. Strong, MA, Kenneth Rosenfield, MD, Matthew T. Menard, MD, Alik Farber, MD, Manesh R. Patel, MD   +13 more
doaj   +5 more sources

Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study

Seminars in Thrombosis and Hemostasis, 2022
International audienceBackground: There is an increased risk of arterial events including major adverse cardiovascular events (MACE) and major adverse limb events (MALE) after venous thromboembolism (VTE).
Nasr, Bahaa, Didier, Romain, Poulhazan, Elise, Noumegni, Steve Raoul, Couturaud, Francis, Bressollette, Luc, Mansourati, Vincent, Tromeur, Cécile, Hoffmann, Clément, Lacut, Karine, Mao, Raphael Le, Moreuil, Claire De, Guegan, Marie, Moigne, Emmanuelle Le, Roux, Pierre-Yves Le, Gentric, Jean-Christophe   +15 more
core   +4 more sources

High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy [PDF]

Atherosclerosis, 2022
Backgrounds and aims: Elevated lipoprotein(a) (Lp[a]) has been identified as a causal risk factor for cardiovascular disease including peripheral arterial disease (PAD).
de Borst, Gert J., Waissi, Farahnaz, Verwer, Maarten C., Hazenberg, Constantijn E.V.B., Mekke, Joost M., Stroes, Erik S.G., Kroon, Jeffrey, de Kleijn, Dominique P.V., Dekker, Mirthe, Zorgeenheid Vaatchirurgie Medisch, Regenerative Medicine and Stem Cells, Brain, Infection & Immunity, Circulatory Health   +13 more
core   +5 more sources

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease [PDF]

Journal of Cardiovascular Pharmacology and Therapeutics, 2022
Peripheral artery disease (PAD) is a severe manifestation of atherosclerosis. Patients with PAD are at heightened risk for atherothrombotic complications, including myocardial infarction and stroke (MACE); however, there is also an equal or greater risk ...
Justin T. Morrison MD, Nicholas Govsyeyev MD, MS, CS, Connie N. Hess MD, MHS, Marc P. Bonaca MD, MPH   +3 more
doaj   +3 more sources

Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease [PDF]

Heart, 2020
Aim: To determine the relationship between non-high-density lipoprotein cholesterol (non-HDL-c), systolic blood pressure (SBP) and smoking and the risk of major adverse limb events (MALE) and the combination with major adverse cardiovascular events (MALE/
Visseren, FLJ, Bots, ML, Asselbergs, FW, De Borst, GJ, Hageman, SHJ, Dorresteijn, JAN, Westerink, J   +6 more
core   +6 more sources

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Thrombosis and Haemostasis, 2020
Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the impact of statins on major adverse limb events (MALE) in PAD patients are lacking.
Pastori, Daniele, Menichelli, Danilo, Hiatt, William R, Farcomeni, Alessio, Del Sole, Francesco, Milanese, Alberto, Violi, Francesco   +6 more
core   +6 more sources

PAD as a Marker of Systemic Atherosclerosis: A Comprehensive Review of Residual Risk and Contemporary Strategies for MACE and MALE Reduction [PDF]

Medicina
Background: Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis associated with substantial risks of major adverse cardiovascular events (MACE) and major adverse limb events (MALE). Scope: This comprehensive review examines the
Giuseppe Miceli, Maria Grazia Basso, Mariagiovanna Cuffaro, Antonino Marchese, Antonino Tuttolomondo   +4 more
doaj   +2 more sources

Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease

The American Journal of Cardiology, 2019
© 2019 Elsevier Inc. Chronic coronary artery disease (CAD) and peripheral artery disease (PAD) are both associated with elevated risks of major adverse cardiovascular events (MACE) and major adverse limb events (MALE).
Bhagnani, Tarun, Zhao, Qi, Leeper, Nicholas J., Ting, Windsor, Simpson, Alex, Nordstrom, Beth, Berger, Ariel, Murphy, Brian, Berger, Jeffrey S.   +8 more
core   +3 more sources

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events.

JAMA Netw Open, 2022
ImportanceHigh lipoprotein(a) (Lp[a]) levels are involved in the development of cardiovascular events, particularly in myocardial infarction, stroke, and peripheral artery disease. Studies assessing the Lp(a) levels associated with adverse lower-limb events are lacking.ObjectiveTo assess the association between Lp(a) levels and incidence of major ...
Guédon AF, De Freminville JB, Mirault T, Mohamedi N, Rance B, Fournier N, Paul JL, Messas E, Goudot G.   +8 more
europepmc   +3 more sources

Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies [PDF]

Cardiovascular Diabetology
Background The impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on peripheral artery disease (PAD) remains uncertain. We assessed the association between GLP-1RA use and major limb events in individuals with type 2 diabetes (T2D) and PAD ...
Paola Caruso, Nicole Di Martino, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito, Dario Giugliano   +7 more
doaj   +2 more sources